PhRMA Statement on Energy & Commerce Health Subcommittee 340B Hearing

Allyson Funk   |     March 24, 2015   |   SHARE THIS


Today, PhRMA CEO John J. Castellani sent the following statement for the record to the Energy and Commerce Health Subcommittee on the hearing they’re holding on the 340B program:



Allyson Funk

Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.

Topics: 340B

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates